London, England, United Kingdom Hikma Ventures is the famous VC, which was founded in 2015. The fund was located in Europe if to be more exact in United Kingdom. Hikma Ventures appeared to be a CVC structure as part of the corporation. The main office of represented VC is situated in the London.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Nebula Genomics, Pillo Health, Biolinq For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in some founders of portfolio startups. Among the most popular fund investment industries, there are Health Care, Therapeutics.
The average startup value when the investment from Hikma Ventures is 50-100 millions dollars. The fund is constantly included in 2-6 investment rounds annually. Considering the real fund results, this VC is 0 percentage points less often commits exit comparing to other organizations. The top amount of exits for fund were in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars. This Hikma Ventures works on 19 percentage points less the average amount of lead investments comparing to the other organizations. The important activity for fund was in 2017. Despite it in 2019 the fund had an activity.
The standard case for the fund is to invest in rounds with 6 partakers. Despite the Hikma Ventures, startups are often financed by Social Capital, Safeguard Scientifics, MentorTech Ventures. The meaningful sponsors for the fund in investment in the same round are Safeguard Scientifics, Social Capital, SR One. In the next rounds fund is usually obtained by Stanley Black & Decker, Social Capital, Samsung Ventures.
We also calculated 2 valuable employees in our database.
Related Funds
Funds with similar focus
| Fund Name | Location |
| 1855 Capital Partners | Pennsylvania, State College, United States |
| Booz Allen Hamilton | Mclean, United States, Virginia |
| Checkr | California, San Francisco, United States |
| Como Venture | Como, Italy, Lombardia |
| Corl | Canada, Ontario, Toronto |
| Dreampact Ventures | Delaware, New Castle, United States |
| Ganxiang Technology | China, Guangdong, Shenzhen |
| Greentree Investment Comany | - |
| Huatai Insurance Group | Beijing, Beijing, China |
| IQS Tech Factory | Barcelona, Catalonia, Spain |
| Lancaster Capital | Glasgow, Glasgow City, United Kingdom |
| One More Japan | Japan, Tokyo |
| PETstock | Australia, South Melbourne, Victoria |
| Sciety | Stockholm, Stockholm County, Sweden |
| SFRE Fund | Luxembourg, Luxembourg |
| Shibolet Capital | Israel, Tel Aviv, Tel Aviv District |
| Tango | Netherlands, Utrecht, Utrecht |
| Tate Family Trust | Alabama, Huntsville, United States |
| Tetragon Financial Group Limited | New York, New York, United States |
| The Jump Brazil | Bahia, Brazil, Recife |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Octave Bioscience | $32M | 26 Jul 2023 | California, United States | ||
O7 Therapy | $2M | 04 Apr 2022 | Cairo, Al Qahirah, Egypt | ||
Altoida, Inc. | $14M | 30 Mar 2022 | Washington, District of Columbia, United States | ||
Altibbi | $44M | 28 Mar 2022 | Dubai, United Arab Emirates | ||
Activ Surgical | $15M | 22 Mar 2022 | Boston, Massachusetts, United States | ||
NuvoAir | $11M | 19 Jan 2022 | Boston, Massachusetts, United States | ||
BioSapien | $1M | 11 Nov 2021 | New York, New York, United States | ||
Biolinq | $100M | 02 Nov 2021 | San Diego, California, United States | ||
Click Therapeutics | $52M | 22 Oct 2021 | New York, New York, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Octave Bioscience | $32M | 26 Jul 2023 | California, United States | ||
O7 Therapy | $2M | 04 Apr 2022 | Cairo, Al Qahirah, Egypt | ||
Altoida, Inc. | $14M | 30 Mar 2022 | Washington, District of Columbia, United States | ||
Altibbi | $44M | 28 Mar 2022 | Dubai, United Arab Emirates | ||
Activ Surgical | $15M | 22 Mar 2022 | Boston, Massachusetts, United States | ||
NuvoAir | $11M | 19 Jan 2022 | Boston, Massachusetts, United States | ||
BioSapien | $1M | 11 Nov 2021 | New York, New York, United States | ||
Biolinq | $100M | 02 Nov 2021 | San Diego, California, United States | ||
Click Therapeutics | $52M | 22 Oct 2021 | New York, New York, United States |
